Tonix Pharmaceuticals Holding Corp
Change company Symbol lookup
Select an option...
TNXP Tonix Pharmaceuticals Holding Corp
AGR Avangrid Inc
OMI Owens & Minor Inc
PSA-U Public Storage
BAC Bank of America Corp
GM General Motors Co
GLW Corning Inc
GILD Gilead Sciences Inc
GG Goldcorp Inc
GEN Genesis Healthcare Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company. The Company's drug development programs are directed toward disorders affecting the central nervous system (CNS), and include fibromyalgia (FM), and post-traumatic stress disorder (PTSD). It is focused on developing a portfolio of product candidates, including one product candidate in clinical development for registration in two indications. TNX-102 SL (cyclobenzaprine hydrochloric acid (HCl) sublingual tablets), is a disintegrating tablet containing cyclobenzaprine (CBP) for sublingual administration. The Company has completed Phase IIb BESTFIT trial of TNX-102 SL for fibromyalgia. It is being evaluated in the Phase III AFFIRM study for the treatment of fibromyalgia. The Company is also conducting AtEase trial, which is a Phase II clinical trial of TNX-102 SL in military-related PTSD. It also has a pipeline of other product candidates, including TNX-301, a fixed dose combination drug product (CDP).

Closing Price
$1.96
Day's Change
0.02 (1.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.97
Day's Low
1.91
Volume
(Below Average)
Volume:
131,433

10-day average volume:
156,915
131,433
  • Prev Close
    1.94
  • Today's Open
    1.92
  • Day's Range
    1.91-1.97
  • Avg Vol (10-day)
    156.9K
  • Last (time)
    3:59p ET 02/20/19
  • Last (size)
    1
  • 52-Wk Range
    1.70 - 51.10
    LowHigh
  • (06/07/18 - 01/31/19)
    15.29%
  • 152.4%
  • Market Cap
    3.0M
  • Shares Outstanding
    1.5M
  • -28.85
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.9
  • 11.14
  • (% of float 01/31/19)
    2.77

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.